Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07605390 · ClinicalTrials.gov registry record · NA
RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)
A NA study, sponsored by Baylor Research Institute.
- Not yet
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT07605390 is a NA study that has not yet begun recruiting, run by Baylor Research Institute. The registered enrollment target is 600 participants.
The verdict
NCT07605390, a NA study, has not yet begun recruiting, sponsored by Baylor Research Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
The goal of this pragmatic randomized clinical trial is to determine whether an Epic-based clinician notification increases initiation of guideline-directed cardio-kidney-metabolic (CKM) therapies in adults with type 2 diabetes and confirmed albuminuria. The main question it aims to answer is: • Does an Epic clinician notification improve initiation of guideline-directed CKM therapies compared with usual care? Researchers will compare an Epic in-basket clinician notification strategy with usual care. In the intervention arm, the treating clinician will receive an Epic notification identifying confirmed albuminuria and potential eligibility for guideline-directed CKM therapies using existing electronic health record (EHR) data. Participants in the usual care arm will receive standard clinical care without notification.
Interventions
- OTHER Usual Care
- OTHER Epic-Based Clinician Notification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2026-08 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07605390
The ClinicalTrials.gov registry entry for NCT07605390 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT07605390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07605390 about?
NCT07605390 is a clinical study titled "RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)". The goal of this pragmatic randomized clinical trial is to determine whether an Epic-based clinician notification increases initiation of guideline-directed cardio-kidney-metabolic (CKM) therapies in adults with type 2 diabetes and confirmed albuminuria. The main question it aims to answer is: • D...
What is the current status of trial NCT07605390?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2026-08. Estimated completion is 2028-01.
What interventions are being tested in trial NCT07605390?
The interventions under investigation include: Usual Care (OTHER), Epic-Based Clinician Notification (OTHER).
Who is sponsoring clinical trial NCT07605390?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.